Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
innovation in Asia—and the possibility to apply for NUS faculty positions upon completing your tenure. Eligibility Criteria Displayed exceptional intellectual ability to produce original work of the highest
-
, conducting research, analyzing data, preparing the work for publication and disseminating results. The work of the post-holder is expected to lead to high-impact publications. Your main tasks and
-
research, analyzing data, preparing the work for publication and disseminating results. The work of the post-holder is expected to lead to high-impact publications. Your main tasks and responsibilities
-
: Isogenic immortalized cell lines generated using CRISPR-Cas genome editing Novel xenograft and transgenic in vivo model systems Induced pluripotent stem cells Primary patient samples Minimum Education and/or
-
CRISPR/Cas9, cloning, protein biochemistry, as well as work with cell cultures and primary patient samples (S1/S2) Conducting and establishing experiments with in vivo mouse models Analysis and
-
, single-cell transcriptomics, proteomics, metabolomics, and network reconstruction. Former trainees of the Chi lab have been principal investigators in multiple academic institutions. Please also see the
-
. The primary criteria for selection will be the alignment of the applicant's existing skills and expertise with the requirements mentioned above. Please note that by applying you consent to share your
-
Post Doctoral Researcher in Human-Centered AI for Software Engineering, Department of Electrical ...
, the proposal of Large Language Models opened a wider range of opportunities to explore its use for Software Engineering (LLM4SE). This is the main goal of this research, i.e., to apply LLMs within
-
/assignment relevant to the subject area. Candidates who have worked in the lab of the main PI or Co-PI during their PhD and postdoc are not eligible. Step 1: Application The application should include: A
-
as well as the stepwise process of leukemogenic transformation. Our approach integrates gene editing in human and murine primary hematopoietic and iPSC-derived stem cells, in vivo zebrafish and mouse